Core Viewpoint - The company, Steady Medical, is currently not prioritizing overseas listing despite the growing trend of A-share companies seeking international capital. The focus remains on domestic growth and market expansion [1][2]. Group 1: Company Strategy - Steady Medical's chairman, Li Jianquan, emphasized that overseas listing is not a current focus, as the domestic market continues to show significant growth potential [1]. - The company previously listed on the US stock market from 2005 to 2012 before returning to the A-share market in September 2020 [1]. Group 2: Financial Performance - For the first half of 2025, Steady Medical reported revenues of 5.296 billion yuan and a net profit attributable to shareholders of 492 million yuan, reflecting year-on-year growth of 31.31% and 28.07%, respectively [2]. - The consumer brand "All Cotton Era" is a key growth driver, generating 2.75 billion yuan in revenue in the first half of 2025, with over 20% year-on-year growth [2]. Group 3: Store Expansion Plans - The annual plan for new stores under "All Cotton Era" has been reduced to 50, down by half from previous projections, due to fewer new commercial real estate projects and a shift towards larger store formats [3]. - The first global flagship store for "All Cotton Era" is set to open in Wuhan, targeting mid-to-high-end consumers and featuring a product range that includes home goods and outdoor apparel [4]. - Future flagship stores are planned for major cities like Beijing, Shanghai, Chengdu, Shenzhen, and Xi'an, with a focus on suitable projects to avoid excessive costs [4].